Most Recent Articles by James G. DIckinson
Would you expect that patient power exerted through social media might shake the job of a high-level FDA center director?
The FDA has to respect First Amendment limitations regulating scientific communication
Medtronic, as part of the settlement, will pay $602,000 to a whistleblower to settle charges it caused physicians to submit false claims to federal health programs.
President Barack Obama's recently unveiled Precision Medicine Initiative hopes to develop a new model of patient-driven research with the promise of accelerating biomedical discoveries and provide clinicians with new tools, knowledge, and therapies.
FDA posted a revised draft guidance document on its brief summary and adequate directions for use concerning risk information in DTC print ads to reflect "recent social science research."
More Articles by James G. DIckinson
- IPO filing reveals Cannes Lions makes $59 million in annual revenue
- Five things for pharma marketers to know: Wednesday, February 10, 2016
- Federal agencies and ad groups join forces for prediabetes campaign
- At Work With: Digitas Health LifeBrands' Jennifer Durante
- Five things for pharma marketers to know: Tuesday, February 9, 2016